Renaissance Capital logo

ATAT News

Renaissance Capital's November IPO Market Update

ACRV

It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain Atour Lifestyle Holdings (ATAT). Two small issuers also slipped through the IPO window despite increased scrutiny from regulators....read more

US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week

INTS

Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two SPACs submitted initial filings. In the pipeline, large IPOs KinderCare Learning Companies (KLC),...read more

Chinese hotel chain Atour Lifestyle Holdings prices US IPO at $11 low end

ATAT

Atour Lifestyle Holdings, an upper midscale hotel chain in China, raised $52 million by offering 4.8 million ADSs at $11, the low end of the range of $11 to $13. The IPO float is just 3.6% of the basic shares outstanding. New investor Snow Lake had indicated on $10 million worth of ADSs in the offering (19% of the deal). Atour Lifestyle offers guests a range...read more

Chinese hotel chain Atour Lifestyle Holdings relaunches $57 million US IPO

ATAT

Atour Lifestyle Holdings, an upper midscale hotel chain in China, filed new terms for its upcoming IPO on Monday. The Shanghai, China-based company now plans to raise $57 million by offering 4.8 million ADSs at a price range of $11 to $13. The IPO float is just 3.6% of the basic shares outstanding, or 3.0% after indicated buying. New investor Snow Lake intends to purchase $10...read more